Stock Taper
WST
WEST PHARMACEUTICAL SERVICES, INC.
NYSE
$342.59
▲ UP 1.52% (5.12)

KEY STATISTICS

Market Cap$23.75 B
52w High$386.00
52w Low$223.83
Dividend Yield0.25%
FrequencyQuarterly
P/E40.30
Volume139.73K
Shares Out.70.38M

COMPANY

LEADERSHIP

Eric Green
CHIEF EXECUTIVE
Eric Green

COMPENSATION 2026

Salary$1,177,290
Stock Awards$3,327,048
Incentive Plan Pay$1,471,613
All Other Comp.$58,159
Total$7,190,876

ABOUT

SECTOR
Healthcare
WENT PUBLIC
March 17, 1980
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
10,800

PRICE TARGET

Target High$447.00
Target Low$365.00
Target Median$400.00
Target Consensus$405.40

UPCOMING EARNINGS

DateOct 22, 2026
DayThursday
Rev. Est.$825.86M
OCT
22
THU

SPLIT RECORD

DATETYPERATIO
2013-09-27Forward2:1
2004-09-30Forward2:1
1987-06-02Forward2:1
1982-05-06Forward2:1

PRICE

$342.59 ▲ UP 1.52% (+$5.12)
OVERLAYS
$338$340$3439:30 AM10:08 AM10:46 AM11:24 AM12:03 PM12:41 PM1:19 PM342.59

About West Pharmaceutical Services, Inc.

https://www.westpharma.com ↗

West Pharmaceutical Services designs and manufactures containment and delivery systems for injectable drugs and healthcare products globally, serving pharmaceutical, biotech, and medical device companies through proprietary and contract manufactur...

INDUSTRY

Medical - Instruments & Supplies

A PRODUCT WEST PHARMACEUTICAL SERVICES, INC. IS KNOWN FOR

West Synchrony™ S1 prefillable syringe system
West Synchrony™ S1 prefillable syringe system

A prefillable syringe system for biologics and vaccines, offering reliable, efficient drug delivery in various configurations including 1 ml and 2.25 ml options with staked needles or Luer lock, tailored for pharmaceutical and biotech companies.

Revenue by Products

IconPRODUCTQ3-2025Q4-2025Q1-2026Q2-2026
Proprietary Products$647.5M $661.8M $694.3M $722.6M
Contract Manufactured Products$157.1M $143.2M

Revenue by Geography

MapREGIONFY2022FY2023FY2024FY2025
UNITED STATES$1.29B $1.24B $1.23B $1.33B
Other Europe Countries$359.2M $388.1M $385.5M $451M
GERMANY$398.7M $406.1M $372.5M $380.3M
Other Countries$364.3M $348.5M $339M $353.3M
IRELAND$240.3M $285.7M $323.2M $333.3M
FRANCE$237.9M $282.9M $242.2M $226.6M

RATINGS SNAPSHOT

Overall rating: B+

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity5
Return On Assets5
Debt To Equity3
Price To Earnings1
Price To Book1
Overall Score3

TRADES BY CONGRESS

HOUSE TRADES
Lisa McClain
Lisa McClain
Sale (Full)
2025-07-22
Rob Bresnahan
Rob Bresnahan
Sale (Full)
2025-04-08
Jared Moskowitz
Jared Moskowitz
Sale (Full)
2025-02-13
Ro Khanna
Ro Khanna
Sale
2024-09-09

INSIDER TRADES

OFFICER: SVP & CHIEF FINANCIAL OFFICER
McMahon Robert W.
Sale · 794 shares
2026-08-11
OFFICER: SVP & CHIEF FINANCIAL OFFICER
McMahon Robert W.
Sale · 6.4K shares
2026-08-11
OFFICER: SVP & CHIEF FINANCIAL OFFICER
McMahon Robert W.
Purchase · 6.4K shares
2026-08-11
OFFICER: SVP & CHIEF FINANCIAL OFFICER
McMahon Robert W.
Sale · 2.8K shares
2026-08-11

MOST RECENT ANALYST GRADES

GRADE SUMMARY
OVERWEIGHT 3
BUY 2
OUTPERFORM 1
EQUAL WEIGHT 1
7 GRADES IN THE LAST 12 MONTHS

SECTORS PEERS

PEERPRICE
ILMN$215.59COMPARE
WAT$414.69COMPARE
LH$335.11COMPARE
DGX$242.76COMPARE
INCY$124.37COMPARE
STE$233.78COMPARE
ZBH$100.91COMPARE
MEDP$600.65COMPARE